Related Experiment Video
Updated: Jul 4, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Immunological aspects of herpetic stromal keratitis
1Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan. yoinoue@med.tottori-u.ac.jp
Insights
Herpetic stromal keratitis (HSK) involves immune responses to herpes simplex virus (HSV) corneal infections. Understanding HSK pathogenesis is key to balancing immune suppression for healing and preventing viral spread.
Area of Science:
- Immunology
- Ophthalmology
- Virology
Background:
- Herpetic stromal keratitis (HSK) is an immune-mediated condition resulting from herpes simplex virus (HSV) corneal infection.
- CD4(+) T lymphocytes, particularly Th1 cells, are primary mediators, with neutrophils and antigen-presenting cells also playing significant roles.
Purpose of the Study:
- To elucidate the immunological aspects and pathogenesis of HSK.
- To explore potential therapeutic strategies like vaccination and address associated challenges.
Main Methods:
- Review of immunological mediators involved in HSK pathogenesis.
- Discussion of molecular mechanisms including cytokine and chemokine involvement.
- Examination of vaccination strategies and autoimmune theories.
Main Results:
- Key immune cells (CD4+ T cells, neutrophils, APCs) and molecules (Th1 cytokines like IL-2, IL-12, IFN-gamma; inflammatory cytokines IL-1α, IL-6; chemokine MIP-1α) are critical.
- Vaccine therapy using glycoprotein D shows promise but faces challenges regarding potential HSK exacerbation.
- Autoimmune theories like molecular mimicry and bystander activation are proposed but remain debated.
Conclusions:
- A comprehensive understanding of HSK pathogenesis is crucial for developing effective treatments.
- Future research must resolve the conflict between managing immune responses to prevent scarring and controlling viral replication.
Abstract:
Herpetic stromal keratitis (HSK) is an immune reaction related to herpes simplex virus (HSV) corneal infection, and has many important immunological aspects. CD4(+) T lymphocytes, especially Th1 cells, are the principal mediators for HSK. In addition, neutrophils and antigen-presenting cells play vital roles in HSK. CD8(+) T lymphocytes, B cells, and natural killer cells all participate in the pathogenesis of HSK under certain circumstances. Many molecules are involved in the pathogenesis of HSK. Th1 cytokines such as interleukin 2 (IL-2), IL-12 and interferon gamma, and inflammatory cytokines such as IL-1alpha and IL-6 are especially important ones. Among various chemokines that take part in HSK, MIP-1alpha is one of the most important aggravating factors. Vaccination therapy against HSK has been developed; glycoprotein D is a particularly promising candidate. However, the possibility of HSK exacerbation due to vaccination is the final problem to be solved before vaccination can be clinically applied to HSK. Molecular mimicry theory and bystander activation theory are the two new autoimmune theories that have been advocated. Since genuine autoimmune HSK without HSV growth can hardly be the case in clinical practice, some part of these new theories remains controversial. In the future, better understanding of the pathogenesis of HSK is essential to resolve the paradox between suppressing the immune reaction to avoid corneal scarring and preventing viral proliferation.
Related Concept Videos
Herpes
Genital Herpes
Encephalitis ll: Pathophysiology

